30 results
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
7 May 24
Intra-cellular Therapies Reports First Quarter 2024 Financial Results
7:40am
of opioid use disorder and pain. A multiple ascending dose study and a positron emission tomography (PET) study are both ongoing.
ITI-1500 Non
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
22 Feb 24
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Corporate Update
7:39am
in the treatment of opioid use disorder and pain. A multiple ascending dose study and a positron emission tomography (PET) study are both ongoing.
ITI
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
2 Nov 23
Intra-cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
8:01am
dose study and a positron emission tomography (PET) study are ongoing.
ITI-1500 Non-Hallucinogenic Psychedelic Program: Our lead product candidate
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
3 Aug 23
Intra-cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
7:39am
disorder and pain. We have completed the single ascending dose study and a multiple ascending dose study and a positron emission tomography (PET) study
8-K
mjsv2w
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am
8-K
EX-99.1
f7pph8 ppw7ch
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am
8-K
EX-99.3
gdj m6mmp
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am
8-K
EX-99.2
chul tndgxv7pl3l3k
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am
8-K
EX-99.4
ut4bk1st
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am